Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10005123142
Objective: To measure the cost effectiveness of a supportive care intervention when the no-treatment option is unrealistic in an analysis of recombinant human erythropoietin (epoetin) treatment for anaemic patients with cancer undergoing chemotherapy. Further, to assess whether quality-adjusted...
Persistent link: https://www.econbiz.de/10005405014
Persistent link: https://www.econbiz.de/10005073514
Objective: The ratio of controller to reliever medication use has been proposed as a measure of treatment quality for asthma patients. In this study we examine the effects of plan level mean out-of-pocket asthma medication patient copayments and other features of benefit plan design on the use...
Persistent link: https://www.econbiz.de/10005103374
Persistent link: https://www.econbiz.de/10001859255
Persistent link: https://www.econbiz.de/10002227651
Persistent link: https://www.econbiz.de/10006966478
Persistent link: https://www.econbiz.de/10006330262
Objective: The ratio of controller to reliever medication use has been proposed as a measure of treatment quality for asthma patients. In this study we examine the effects of plan level mean out-of-pocket asthma medication patient copayments and other features of benefit plan design on the use...
Persistent link: https://www.econbiz.de/10012468632
Objective: The ratio of controller to reliever medication use has been proposed as a measure of treatment quality for asthma patients. In this study we examine the effects of plan level mean out-of-pocket asthma medication patient copayments and other features of benefit plan design on the use...
Persistent link: https://www.econbiz.de/10013221321